Aytu BioPharma Inc. (AYTU)

NASDAQ: AYTU · Real-Time Price · USD

1.30

-0.03 (-2.62%)

At close: May 02, 2025, 12:28 PM

Aytu BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Cash & Equivalents	20.01M	22.98M	19.36M	49.65M	48.08M	11.04M	7.01M	802.33K	8.05M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.04M
Long-Term Investments	n/a	-1.38M	n/a	-10.91M	-1.8M	n/a	n/a	n/a	n/a
Other Long-Term Assets	2.23M	792K	766K	465K	32.98K	2.2K	4.72K	2.89K	216.36K
Receivables	23.62M	28.94M	21.71M	28.18M	5.63M	1.74M	578.78K	528.04K	162.43K
Inventory	12.63M	11.99M	10.85M	16.34M	10M	1.44M	1.34M	1.31M	524.71K
Other Current Assets	5.63M	868K	633K	1.29M	5.99M	250K	100K	75.21K	121.98K
Total Current Assets	61.89M	72.83M	59.93M	105.23M	74.97M	15.43M	9.47M	3.03M	10.12M
Property-Plant & Equipment	1.52M	3.87M	6.3M	8.7M	892.61K	203.73K	219K	647.25K	231.43K
Goodwill & Intangibles	52.45M	58.97M	70.63M	151.27M	76.94M	19.08M	11.37M	11.32M	13.77M
Total Long-Term Assets	56.2M	63.63M	77.69M	160.43M	77.87M	19.29M	11.59M	11.97M	14.22M
Total Assets	118.09M	136.46M	137.62M	265.67M	152.84M	34.72M	21.06M	15M	24.34M
Account Payables	10.44M	13.48M	10.99M	19.25M	11.64M	2.13M	2.12M	2.22M	2.32M
Deferred Revenue	n/a	46.8M	n/a	57.23M	339.34K	n/a	n/a	n/a	n/a
Short-Term Debt	4.25M	85K	3.91M	24.6M	982K	n/a	n/a	n/a	n/a
Other Current Liabilities	24.85M	49.78M	15.89M	34.76M	5.54M	2.23M	734.43K	1.05M	6.58M
Total Current Liabilities	62.23M	69.02M	64.44M	109.44M	28.31M	5.37M	3.39M	3.61M	10.1M
Long-Term Debt	10.88M	14.71M	14.2M	2.8M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	17.27M	13.38M	12.81M	13.23M	28.79M	22.26M	4.24M	7.39M	4.15M
Total Long-Term Liabilities	28.15M	28.09M	27.09M	18.66M	29.51M	22.26M	4.24M	7.39M	4.15M
Total Liabilities	90.38M	97.11M	91.53M	128.1M	57.82M	27.63M	7.64M	11M	14.26M
Total Debt	15.13M	16.36M	18.19M	28.35M	2.01M	n/a	n/a	n/a	n/a
Common Stock	1K	1K	4K	3K	12.58K	1.75K	179.00	82.00	374.00
Retained Earnings	-319.97M	-304.13M	-288.47M	-178.3M	-120.01M	-106.39M	-79.26M	-69.07M	-46.56M
Comprehensive Income	n/a	n/a	-0.00	0.00	n/a	n/a	0.00	-246K	-112K
Shareholders Equity	27.72M	39.36M	46.09M	137.57M	95.02M	7.09M	13.42M	4M	10.09M
Total Investments	-762K	-1.38M	n/a	-10.91M	-1.8M	n/a	n/a	n/a	1.04M